# COVAXIN in a Pediatric Cohort

> **NCT04918797** · PHASE2,PHASE3 · COMPLETED · sponsor: **Bharat Biotech International Limited** · enrollment: 525 (actual)

## Conditions studied

- SARS-CoV2 Infection

## Interventions

- **BIOLOGICAL:** COVAXIN

## Key facts

- **NCT ID:** NCT04918797
- **Lead sponsor:** Bharat Biotech International Limited
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2,PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2021-05-26
- **Primary completion:** 2021-08-15
- **Final completion:** 2022-01-25
- **Target enrollment:** 525 (ACTUAL)
- **Last updated:** 2022-08-18


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04918797

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04918797, "COVAXIN in a Pediatric Cohort". Retrieved via AI Analytics 2026-06-22 from https://api.ai-analytics.org/clinical/NCT04918797. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*